BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 23498719)

  • 1. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
    Rushlow DE; Mol BM; Kennett JY; Yee S; Pajovic S; Thériault BL; Prigoda-Lee NL; Spencer C; Dimaras H; Corson TW; Pang R; Massey C; Godbout R; Jiang Z; Zacksenhaus E; Paton K; Moll AC; Houdayer C; Raizis A; Halliday W; Lam WL; Boutros PC; Lohmann D; Dorsman JC; Gallie BL
    Lancet Oncol; 2013 Apr; 14(4):327-34. PubMed ID: 23498719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RB1 gene inactivation by chromothripsis in human retinoblastoma.
    McEvoy J; Nagahawatte P; Finkelstein D; Richards-Yutz J; Valentine M; Ma J; Mullighan C; Song G; Chen X; Wilson M; Brennan R; Pounds S; Becksfort J; Huether R; Lu C; Fulton RS; Fulton LL; Hong X; Dooling DJ; Ochoa K; Mardis ER; Wilson RK; Easton J; Zhang J; Downing JR; Ganguly A; Dyer MA
    Oncotarget; 2014 Jan; 5(2):438-50. PubMed ID: 24509483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.
    Dimaras H; Khetan V; Halliday W; Orlic M; Prigoda NL; Piovesan B; Marrano P; Corson TW; Eagle RC; Squire JA; Gallie BL
    Hum Mol Genet; 2008 May; 17(10):1363-72. PubMed ID: 18211953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression.
    Kooi IE; Mol BM; Moll AC; van der Valk P; de Jong MC; de Graaf P; van Mil SE; Schouten-van Meeteren AY; Meijers-Heijboer H; Kaspers GL; Te Riele H; Cloos J; Dorsman JC
    EBioMedicine; 2015 Jul; 2(7):660-70. PubMed ID: 26288838
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Price EA; Patel R; Scheimberg I; Kotiloglu Karaa E; Sagoo MS; Reddy MA; Onadim Z
    Ophthalmic Genet; 2021 Oct; 42(5):604-611. PubMed ID: 34003079
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomic differences between retinoma and retinoblastoma.
    Sampieri K; Mencarelli MA; Epistolato MC; Toti P; Lazzi S; Bruttini M; De Francesco S; Longo I; Meloni I; Mari F; Acquaviva A; Hadjistilianou T; Renieri A; Ariani F
    Acta Oncol; 2008; 47(8):1483-92. PubMed ID: 18785023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rb suppresses human cone-precursor-derived retinoblastoma tumours.
    Xu XL; Singh HP; Wang L; Qi DL; Poulos BK; Abramson DH; Jhanwar SC; Cobrinik D
    Nature; 2014 Oct; 514(7522):385-8. PubMed ID: 25252974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
    Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
    Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI Features for Identifying
    Jansen RW; de Bloeme CM; Cardoen L; Göricke S; van Elst S; Jessen JL; Ramasubramanian A; Skalet AH; Miller AK; Maeder P; Uner OE; Hubbard GB; Grossniklaus H; Boldt HC; Nichols KE; Brennan RC; Sen S; Sirin S; Brisse HJ; Galluzzi P; Dommering CJ; Castelijns JA; van der Valk P; Boellaard R; Dorsman J; Moll AC; de Jong MC; de Graaf P
    Radiology; 2023 Jun; 307(5):e222264. PubMed ID: 37191489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families.
    Li WL; Buckley J; Sanchez-Lara PA; Maglinte DT; Viduetsky L; Tatarinova TV; Aparicio JG; Kim JW; Au M; Ostrow D; Lee TC; O'Gorman M; Judkins A; Cobrinik D; Triche TJ
    J Mol Diagn; 2016 Jul; 18(4):480-93. PubMed ID: 27155049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Level
    Roohollahi K; de Jong Y; van Mil SE; Fabius AWM; Moll AC; Dorsman JC
    Ophthalmol Sci; 2022 Sep; 2(3):100188. PubMed ID: 36245757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary enucleated retinoblastoma with MYCN amplification.
    Moulin AP; Stathopoulos C; Marcelli F; Schoumans Pouw J; Beck-Popovic M; Munier FL
    Ophthalmic Genet; 2021 Jun; 42(3):354-359. PubMed ID: 33870828
    [No Abstract]   [Full Text] [Related]  

  • 14. A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence.
    Wu N; Jia D; Bates B; Basom R; Eberhart CG; MacPherson D
    J Clin Invest; 2017 Mar; 127(3):888-898. PubMed ID: 28165337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour.
    Zhang H; Konjusha D; Rafati N; Tararuk T; Hallböök F
    Cell Oncol (Dordr); 2024 Feb; 47(1):209-227. PubMed ID: 37606819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics and Molecular Diagnostics in Retinoblastoma--An Update.
    Soliman SE; Racher H; Zhang C; MacDonald H; Gallie BL
    Asia Pac J Ophthalmol (Phila); 2017; 6(2):197-207. PubMed ID: 28399338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How does MYCN amplification make neuroblastomas behave aggressively? Still more questions than answers.
    Maris JM
    Pediatr Blood Cancer; 2005 Dec; 45(7):869-70. PubMed ID: 16206200
    [No Abstract]   [Full Text] [Related]  

  • 18. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
    Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
    Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1.
    Bowles E; Corson TW; Bayani J; Squire JA; Wong N; Lai PB; Gallie BL
    Genes Chromosomes Cancer; 2007 Feb; 46(2):118-29. PubMed ID: 17099872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of the p53 pathway in retinoblastoma.
    Laurie NA; Donovan SL; Shih CS; Zhang J; Mills N; Fuller C; Teunisse A; Lam S; Ramos Y; Mohan A; Johnson D; Wilson M; Rodriguez-Galindo C; Quarto M; Francoz S; Mendrysa SM; Guy RK; Marine JC; Jochemsen AG; Dyer MA
    Nature; 2006 Nov; 444(7115):61-6. PubMed ID: 17080083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.